Association of polypharmacy and burden of comorbidities on COVID-19 adverse outcomes in people with type 1 or type 2 diabetes https://www.medrxiv.org/content/10.1101/2023.08.12.23294016
Association of polypharmacy and burden of comorbidities on COVID-19 adverse outcomes in people with type 1 or type 2 diabetes https://www.medrxiv.org/content/10.1101/2023.08.12.23294016